Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role

Background Angiographic and electrocardiographic (ECG) indexes of microvascular obstruction (MVO) have been described. We aimed at assessing by cardiac magnetic resonance (CMR) anatomical features underlying concordance between them. Methods Forty-one patients were enrolled. Patients presented with neither angiographic nor ECG indexes of MVO (without MVO) (44%), with either angiographic or ECG indexes of MVO (discordant with MVO) (22%) or with both angiographic and ECG indexes of MVO (concordant with MVO) (34%). All patients underwent in-hospital CMR. Echocardiographic data obtained after 6 months were compared with those obtained in hospital. Results Concordant patients with MVO had larger infarct size, lower myocardial salvage index and higher rate of myocardial haemorrhage (all assessed by CMR) [33% (25–41%), 15% (10–29%) and 88%, respectively] as compared with patients without MVO [12% (9–16%), 66% (52–79%) and 0%; Bonferroni-adjusted P < 0.001, Bonferroni-adjusted P < 0.001 and P < 0.001, respectively], or with discordant ones [25% (21–39%), 35% (20–48%) and 7%; Bonferroni-adjusted P = 0.03, Bonferroni-adjusted P = 0.002 and P = 0.04, respectively]. After 6 months, ejection fraction significantly decreased in concordant patients with MVO (P < 0.001) without significant changes in the other groups. Conclusions Concordance of angiographic and ECG indexes of MVO reflects more severe myocardial damage translating into unfavourable left ventricular remodelling.

[1]  S. Plein,et al.  Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. , 2013, International journal of cardiology.

[2]  E. Romagnoli,et al.  Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitropruss , 2013, JACC. Cardiovascular interventions.

[3]  R. Kim,et al.  Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. , 2012, Radiology.

[4]  R. Erbel,et al.  Lessons from human coronary aspirate. , 2012, Journal of molecular and cellular cardiology.

[5]  Mihaela Pop,et al.  Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI , 2011, Magnetic resonance in medicine.

[6]  S. Plein,et al.  Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling. , 2011, Radiology.

[7]  F. Burzotta,et al.  Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling , 2011, Coronary artery disease.

[8]  G. Schuler,et al.  Prognostic value and determinants of a hypointense core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation myocardial infarction , 2011, Circulation. Cardiovascular imaging.

[9]  J. Lima,et al.  MRI in acute myocardial infarction. , 2011, European heart journal.

[10]  D. O’Regan,et al.  Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction , 2010, Heart.

[11]  J. Tijssen,et al.  Prediction of 1-Year Mortality With Different Measures of ST-Segment Recovery in All-Comers After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction , 2010, Circulation. Cardiovascular quality and outcomes.

[12]  M. Friedrich,et al.  Hemorrhage in the myocardium following infarction. , 2010, JACC. Cardiovascular imaging.

[13]  R. Virmani,et al.  Microvascular obstruction: underlying pathophysiology and clinical diagnosis. , 2010, Journal of the American College of Cardiology.

[14]  L. Badimón,et al.  Controlling the angiogenic switch in developing atherosclerotic plaques: Possible targets for therapeutic intervention , 2009, Journal of angiogenesis research.

[15]  F. Burzotta,et al.  Myocardial no-reflow in humans. , 2009, Journal of the American College of Cardiology.

[16]  F. Van de Werf,et al.  Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. , 2009, European heart journal.

[17]  K. Dickstein,et al.  C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. , 2009, European heart journal.

[18]  Joseph V Hajnal,et al.  Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. , 2009, Radiology.

[19]  R. Kloner,et al.  Coronary no‐reflow phenomenon: From the experimental laboratory to the cardiac catheterization laboratory , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[20]  S. Butman,et al.  The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention. , 2008, Cardiovascular revascularization medicine : including molecular interventions.

[21]  Harlan M Krumholz,et al.  Time to treatment in primary percutaneous coronary intervention. , 2007, The New England journal of medicine.

[22]  S. Iliceto,et al.  Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. , 2007, The American journal of cardiology.

[23]  E. Stępień,et al.  No-Reflow Phenomenon After Acute Myocardial Infarction Is Associated With Reduced Clot Permeability and Susceptibility to Lysis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[24]  E. Romagnoli,et al.  Relation of myocardial blush grade to microvascular perfusion and myocardial infarct size after primary or rescue percutaneous coronary intervention. , 2007, American Journal of Cardiology.

[25]  R. Kloner,et al.  The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion , 2006, Basic Research in Cardiology.

[26]  E. Romagnoli,et al.  Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. , 2006, European heart journal.

[27]  R. Blindt,et al.  Association of C-reactive protein and myocardial perfusion in patients with ST-elevation acute myocardial infarction. , 2006, Atherosclerosis.

[28]  G. Thiene,et al.  The pathophysiology of myocardial reperfusion: a pathologist’s perspective , 2006, Heart.

[29]  J. Núñez,et al.  Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. , 2005, Journal of the American College of Cardiology.

[30]  G. Montalescot,et al.  The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes , 2005, Diabetes & vascular disease research.

[31]  B. Gersh,et al.  Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. , 2005, European heart journal.

[32]  E. Antman,et al.  Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. , 2004, American heart journal.

[33]  E. Antman,et al.  Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. , 2004, The American journal of cardiology.

[34]  G. Parodi,et al.  Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction , 2004, Circulation.

[35]  L. Galiuto Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification , 2004, Heart.

[36]  J. Schulz-Menger,et al.  Detection of Acutely Impaired Microvascular Reperfusion After Infarct Angioplasty With Magnetic Resonance Imaging , 2003, Circulation.

[37]  R. Testa,et al.  Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina. , 2002, Journal of the American College of Cardiology.

[38]  Katherine C. Wu,et al.  Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction , 2002, Circulation.

[39]  S. de Servi,et al.  Integrated Analysis of Myocardial Blush and ST-Segment Elevation Recovery After Successful Primary Angioplasty: Real-Time Grading of Microvascular Reperfusion and Prediction of Early and Late Recovery of Left Ventricular Function , 2002, Circulation.

[40]  George Dangas,et al.  Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. , 2002, Journal of the American College of Cardiology.

[41]  R. Gibbons,et al.  TIMI Myocardial Perfusion Grade and ST Segment Resolution: Association With Infarct Size as Assessed by Single Photon Emission Computed Tomography Imaging , 2002, Circulation.

[42]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[43]  Katherine C. Wu,et al.  Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. , 2000, Circulation.

[44]  M. Pepys,et al.  C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.

[45]  Katherine C. Wu,et al.  Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. , 1998, Journal of the American College of Cardiology.

[46]  K. Iwakura,et al.  Assessing the relation between coronary reflow and myocardial reflow. , 1998, The American journal of cardiology.

[47]  H. Suryapranata,et al.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. , 1998, Circulation.

[48]  M. Ovize,et al.  A fresh look at reperfusion injury. , 1998, Cardiovascular research.

[49]  L. Barrios,et al.  Infarct size, myocardial hemorrhage, and recovery of function after mechanical versus pharmacological reperfusion: effects of lytic state and occlusion time. , 1997, Circulation.

[50]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[51]  K Wegscheider,et al.  Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. , 1995, Journal of the American College of Cardiology.

[52]  W. O’Neill,et al.  Features and outcome of no-reflow after percutaneous coronary intervention. , 1995, The American journal of cardiology.

[53]  K. Wegscheider,et al.  Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. , 1994, Journal of the American College of Cardiology.

[54]  D. Baim,et al.  Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. , 1994, Circulation.

[55]  S. Bishop,et al.  Assessment of Postreperfusion Myocardial Hemorrhage Using Proton NMR Imaging at 1.5 T , 1992, Circulation.

[56]  A. Kitabatake,et al.  Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.

[57]  F. Fernández‐Avilés,et al.  Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. , 1990, The American journal of pathology.

[58]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[59]  T. Carew,et al.  The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion. , 1987, Circulation.

[60]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[61]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[62]  D. Durrer,et al.  Tissue Osmolality, Cell Swelling, and Reperfusion in Acute Regional Myocardial Ischemia in the Isolated Porcine Heart , 1981, Circulation research.